Home » Newsletters » BioWorld Science

BioWorld Science

May 23, 2014

View Archived Issues

Toxin-specific MAbs show efficacy in hamster model of CDAD

Urothelial carcinogen resistance model developed in rats

Interferon alpha inhibitor shows promise for the treatment of HIV encephalitis

Daiichi Sankyo recaps events of fourth quarter of fiscal 2013

Neurotrope and Stanford University collaborate on bryologs

Russian and U.S. researchers design new antibodies for HCV infection

Ensemble Therapeutics presents novel IL-17R modulators

Novel azithromycin derivative identified for pulmonary inflammation

Sanofi divulges novel P2Y12 receptor antagonists for thrombotic disorders

RedHill Biopharma and IntelGenx report promising RHB-103 bioavailability data

Adamas Pharmaceuticals receives milestone payment from Forest Laboratories

FDA grants orphan drug status to retinitis pigmentosa treatment candidate

IBI-302 investigated for AMD in vitro and in vivo

NIH funding to support Cognition Therapeutics' work in Alzheimer's disease

Oral fenretinide studied in new phase I trial in cystic fibrosis

WILEX and UCB terminate oncology collaboration

Gedeon Richter to buy majority stake in marketing company Mediplus

Empagliflozin evaluated in patients with diabetes and hypertension in phase III trials

CHMP issues positive opinion for Envarsus in kidney and liver transplant patients

Janssen withdraws application for intravenously administered Simponi in E.U.

Lanthio Pharma receives Dutch government loan to develop novel therapy for lung fibrosis

Avipero and Fusion Antibodies collaborate to humanize integrin antibodies

Sanford-Burnham and Daiichi Sankyo collaborate in cardiovascular-metabolic diseases

Neurotez and GCA Therapeutics sign Chinese license agreement for leptin derivatives

FDA extends Zerenex PDUFA goal date

Nuvilex initiates preclinical studies targeting pancreatic cancer pain and ascites

Empagliflozin approved in E.U.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...